International Journal of Preclinical and Clinical Research
International Journal of Preclinical and Clinical Research (IJPCCR) had adopted the following journal policies.
In order to ensure maximum reach of International Journal of Preclinical and Clinical Research contents, we have adopted the open access policy, meaning that, all the articles published in International Journal of Preclinical and Clinical Research are made freely accessible online immediately after publication in an easily readable format, without any subscription or registration barrier.
All the manuscripts submitted to International Journal of Preclinical and Clinical Research will be subjected to double blinded peer review process;
a. Initial submission
Once submitted, your manuscript will be assigned to a member of our Editorial Board, who will read the paper and decide whether it is appropriate for the journal. Manuscripts that are within scope and seem, on initial assessment, to be technically sound and scientifically valid, will be sent to external reviewers. Copies of any papers containing similar or related work under consideration or in press at other journals must be included with the submission.
b. Peer review
At the submission stage, authors may indicate a limited number of scientists who should not review the paper. Excluded scientists must be identified by name. Authors may also suggest potential reviewers; these suggestions are often helpful, but they are not always followed. By policy, referees are not identified to the authors, except at the request of the referee.
c. Decision after review
After considering the reviewer reports the Editorial Board Member will make one of the following decisions:
d. Revisions
In cases where the referees or Editorial Board Member has requested changes to the manuscript, you will be invited to prepare a revision. The decision letter will specify a deadline for submission of a revised manuscript. Once resubmitted, the manuscript may then be sent back to the original referees or to new referees, at the Editorial Board Member's discretion.
A revised manuscript should be submitted not as a new manuscript. The revision should also be accompanied by a point-by-point response to referees explaining how the manuscript has been changed.
e. Final submission and acceptance
When all editorial issues are resolved, your paper will be formally accepted for publication. After acceptance, authors are sent proofs of their manuscript but only changes to the title, author list or scientific errors will be permitted. All corrections must be approved by the publishing team.
Manuscripts should be formatted according to the instructions given in author guidelines.
To fully realize the potential of open access to research literature, barriers to reuse need to be removed. The Creative Commons (CC) licenses have emerged as an effective legal instrument to achieve this.
Instead of transferring rights exclusively to publishers (the approach usually followed in subscription publishing), authors grant a non-exclusive license to the publisher to distribute the work, and all users and readers are granted rights to reuse the work.
CC-BY allows for unrestricted reuse of content, subject only to the requirement that the source work is appropriately attributed. The CC-BY license thereby requires that authors are given appropriate credit for their work, as explained in a recent post from Creative Commons (http://wiki.creativecommons.org/BIS_committee_UK_OA_Policy)
This journal utilizes the AWS system to create permanent archives of the journal for purposes of preservation and restoration.
Authors who publish in our IJPCCR journal agree to the following terms and conditions:
1) The Creative Commons License for reuse and permission
a. How to attribute under the following terms
The IJPCCR is an electronic Double Blind peer reviewed journal upholding the highest standards. Articles not in accordance with publication ethics and malpractices will be removed from publication if detected at any time. Plagiarism and research fabrication such as making up of data, manipulation of existing data, tables etc. and ethical clearance on the use of humans or animals for the study will also be checked. The journal reserves the right to use plagiarism detecting software to screen submitted papers at any time and suspected plagiarism or duplicate publishing will be reported immediately.
The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may also be stated. IJPCCR hold no responsibility with regard to jurisdictional claims in published institutional affiliations.
Authorship provides credit for a researcher’s contributions to a study and carries accountability. Each author is expected to have made substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data.
All authors to have agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
The corresponding (submitting) author is solely responsible for communicating with IJPCCR and for managing communication between co-authors. Before submission, the corresponding author ensures that all authors are included in the author list, its order has been agreed by all authors, and that all authors are aware that the paper was submitted.
After acceptance, the proof is sent to the corresponding author. He/She is responsible for the accuracy of all content in the proof, in particular that names of co-authors are present and correctly spelt, and that addresses and affiliations are current.
IJPCCR regards the corresponding author as the point of contact for queries about the published paper. It is this author's responsibility to inform all co-authors of matters arising and to ensure such matters are dealt with promptly.
This author does not have to be the senior author of the paper or the author who actually supplies materials; this author's role is to ensure enquiries are answered promptly on behalf of all the co-authors.
IJPCCR treats the submitted manuscript and all communication with authors and referees as confidential. Authors must also treat communication with IJPCCR as confidential. Correspondence, referee reports and other confidential material must not be posted on any website or otherwise publicized without prior permission from the IJPCCR.
Authors may suggest potential reviewers but please keep in mind that we are not obliged to follow these recommendations. The decision of the Editorial Board Members on the choice of referees is final.
Material submitted to IJPCCR should not be discussed with the media, except in the case permitted by the editorial board in writing.
Authors must ensure that
Articles should be submitted using online procedures. Simultaneous publication in more than one publication is a breach of publication ethics.
Committee on Publication Ethics (COPE) during the 2nd World Conference on Research Integrity in Singapore in 2010 has developed the below mentioned guidelines. Sciresol Journals, as a publisher follows COPE, WAME and has adopted COPE’s best practice guidelines for dealing with ethical issues in a journal. The Journal Members (Advisory Board, editors and the journal manager) have consented to adopt the COPE as it meets the purpose and objective of the Journal.
The following is a summary of COPE’s international standards for authors of scholarly research publications and describes responsible research reporting practice. The comprehensive guidelines can be downloaded here
They must ensure that
IJPCCR will consider manuscripts reporting results from well-conducted clinical trials. The trials must be conducted as per ICH-GCP guidelines. We require all clinical trials to be registered in CTRI (Clinical Trial Registry of India) and the registration numbers and date of registration should be added to all relevant manuscripts. These details will be published with the manuscript. Manuscripts reporting clinical trials should be submitted with their protocols as a separate document.
Articles reporting meta-analyses must be accompanied by a completed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist and flow diagram, available at www.prisma-statement.org.
They must ensure that
In case, plagiarism is detected during review/editorial process, such manuscript(s) will be rejected immediately and we can also consider other steps depending upon the seriousness of the case. If the plagiarism is proven after publication, such manuscript(s) will be removed from our website and appropriate announcement will be placed in this regards.
Further, International Journal of Preclinical and Clinical Research can bring such instances in notice of author's funding agencies, author's institutes (where they work) and to the original authors whose work has been plagiarized. Please report the plagiarism to [email protected]
Decisions about types of correction are made by the journal's in-house editors, sometimes with the advice of referees, Editorial Advisory Panel or Editorial Board Members. This process involves consultation with the authors of the paper, but the in-house editors make the final decision about whether an amendment is required and the category in which the amendment is published.
Authors sometimes request a correction to their published contribution that does not affect the contribution in a significant way or impair the reader's understanding of the contribution In these cases, the fact that a correction has been made is stated in a footnote so that readers are aware that the originally published text has been amended.
Material submitted to IJPCCR must be original and not published or submitted for.
Duplicate publication occurs when an author re-uses substantial parts of his or her own published work without providing the appropriate references. This can range from getting an identical paper published in multiple journals, to slicing of the paper, where authors add small amounts of new data to a previous paper.
IJPCCR is happy to consider submissions containing material that has previously formed part of a Ph.D. or other academic thesis which has been published according to the requirements of the institution awarding the qualification.
IJPCCR allows publication of meeting abstracts before the full contribution is submitted. Such abstracts should be included with the submission and referred to in the cover letter accompanying the manuscript. This policy does not extend to meeting abstracts and reports available to the media or which are otherwise publicized outside the scientific community during the submission and consideration process.
Publishing work in conference proceedings is common in some research communities. We are happy to consider submissions containing material that has been published in a conference proceedings paper. However, the submission should provide a substantial extension of results, analysis, conclusions and/or implications over the conference proceedings paper. Authors must provide details of the conference proceedings paper with their submission including a relevant citation in the submitted manuscript. Authors must obtain all necessary permissions to re-use previously published material and attribute appropriately.
If an author of a submission is re-using a figure or figures published elsewhere, or that is copyrighted, the author must provide documentation that the previous publisher or copyright holder has given permission for the figure to be re-published.
Authors must abide by these policies after submission of their manuscript.
Supporting data must be made available to Editorial Board Members and referees at the time of submission for the purposes of evaluating the manuscript. Referees may be asked to comment on the terms of access to materials, methods and/or data sets; IJPCCR reserves the right to refuse publication in cases where authors do not provide adequate assurances that they can comply with the publication's requirements for sharing materials.
The author(s) of each article appearing in this Journal is/are solely responsible for the content thereof; neither the International Journal of Preclinical and Clinical Research nor its editors or publisher or anyone else involved in creating, producing or distribution assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the Journal, nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of International Journal of Preclinical and Clinical Research.
Plagiarism is unacknowledged copying or an attempt to misattribute original authorship, whether of ideas or text. As defined by the ORI (Office of Research Integrity), plagiarism can include, “theft or misappropriation of intellectual property and the substantial unattributed textual copying of another's work”. Plagiarism can be said to have clearly occurred when large chunks of text have been cut-and-pasted without appropriate and unambiguous attribution. Such manuscripts would not be considered for publication in IJPCCR. When re-using text, whether from the author's own publication or that of others, appropriate attribution and citation is necessary to avoid creating a misleading perception of unique contribution for the reader.
IJPCCR Editors and Editorial Board members assess all such cases on their individual merits. When plagiarism becomes evident post-publication, we may correct or retract the original publication depending on the degree of plagiarism, context within the published article and its impact on the overall integrity of the published study.
For every Journal, the peer review process is at the heart of the success of publishing. As part of our commitment to the protection and enhancement of the peer review process, The International Journal of Preclinical and Clinical Research would like to ensure that all published articles are within the accepted level of plagiarism. The Journal uses the very well and widely accepted Plagiarism Detection tool, iThenticate. All submitted Manuscripts are first subjected to Plagiarism check and then the Publishing cycle begins.
In case, plagiarism is detected during review/editorial process, such manuscript(s) will be rejected immediately and we can also consider other steps depending upon the seriousness of the case. If the plagiarism is proven after publication, such manuscript(s) will be removed from our website and appropriate announcement will be placed in this regards. Further, International Journal of Preclinical and Clinical Research can bring such instances in notice of author's funding agencies, author's institutes (where they work) and to the original authors whose work has been plagiarized. Please report the plagiarism to [email protected]
In the interests of transparency and to help readers to form their own judgments of potential bias, authors must declare any competing financial and/or non-financial interests in relation to the work described.
Competing interests are defined as financial and non-financial interests that could directly undermine, or be perceived to undermine, the objectivity, integrity and value of a publication, through a potential influence on the judgements and actions of authors with regard to objective data presentation, analysis and interpretation.
a. Financial Competing Interest
b. Non-financial Competing Interest
Non-financial competing interests can take different forms, including personal or professional relations with organizations and individuals. We would encourage authors and referees to declare any unpaid roles or relationships that might have a bearing on the publication process. Examples of non-financial competing interests include (but are not limited to):
The corresponding author is responsible for submitting a competing interest’s statement on behalf of all authors of the paper. We do not require authors to state the monetary value of their financial interests.
IJPCCR request the peer-reviewers to exclude themselves in cases where there is a significant conflict of interest, financial or otherwise. However, just as financial interests need not invalidate the conclusions of an article, nor do they automatically disqualify an individual from evaluating it. We ask peer-reviewers to inform the editors of any related interests, including financial interests as defined above that might be perceived as relevant.
Editorial Board Members are required to declare any interests that might influence, or be perceived to influence, their editorial activities. In particular, they should exclude themselves from handling manuscripts in cases where there is a conflict of interest, financial or otherwise. This may include – but is not limited to – having previously published with one or more of the authors, and sharing the same institution as one or more of the authors.
Editorial Board Members are welcome to submit papers to the journal. These submissions are not given any priority over other manuscripts, and Editorial Board Member status has no bearing on editorial consideration. When an Editorial Board Member is an author on a submission, they will have no involvement in the editorial review of the manuscript, no access to confidential information on the editorial process, and no input into the decision to publish the article.
Editor’s decision is the decisive factor for all scholarly publications. However, this decision is based on Editorial Policies – which includes plagiarism, copyright etc. It becomes important to retain the Published articles as it is – without any alterations. However, owing to certain circumstances, a published article may at times be retracted, removed or may require a change.
Retraction could be due to:
The article PDF will remain available with the watermark “Retracted” available on it. Only in case of legal/controversial/incorrect PDF, they will be replaced or removed completely from the website with a note.
Subscribe now for latest articles and news.